Delivery Order SPE2DB22D3016-SPE2DB25FBKP8
- Not listed
- The Defense Logistics Agency awarded a $34,113.36 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of VYVGART 400 mg/20 mL vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 ml vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This competitive, firm fixed-price delivery order carries a ceiling value of $8,528.34 and is due for completion by August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of VYVGART 400 mg/20 mL vials on July 28, 2025, with a completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $34,113.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYVGART 400 MG/20 ML vials on September 8, 2025, with completion targeted for September 29, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,528.34 to AmerisourceBergen Drug Corp for VYVGART 400 MG/20 ML vials (20 ML). This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 28, 2025, is for Vyvgart 400 mg/20 mL vials totaling $17,056.68 under a firm fixed-price arrangement. The contract is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and is scheduled for completion by September 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction,...
- The Defense Logistics Agency awarded a delivery order valued at $8,528.34 to AmerisourceBergen Drug Corp for the supply of VYVGART 400 mg/20 mL vials on August 19, 2025. This firm fixed price, non-set-aside contract is scheduled for completion by September 10, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. VYVGART is a specialty pharmaceutical product used in the treatment of myasthenia gravis, reflecting the Defense Logistics...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKP8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of VYVGART 400 mg/20 ml vials with a ceiling value of $38,377.53. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition in accordance with federal procurement standards. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical commodities to support military and veteran healthcare systems. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive awards positions it as a key supplier within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 9/23/25 |